Revance Therapeutics (NASDAQ:RVNC) Price Target Lowered to $8.00 at The Goldman Sachs Group
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Related Keywords